Wolverine Trading’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.16M | Sell |
43,819
-20,276
| -32% | -$538K | ﹤0.01% | 369 |
|
2025
Q1 | $1.64M | Buy |
64,095
+16,327
| +34% | +$419K | ﹤0.01% | 262 |
|
2024
Q4 | $1.9M | Sell |
47,768
-7,743
| -14% | -$308K | ﹤0.01% | 367 |
|
2024
Q3 | $3.42M | Buy |
55,511
+37,462
| +208% | +$2.31M | ﹤0.01% | 124 |
|
2024
Q2 | $957K | Sell |
18,049
-2,925
| -14% | -$155K | ﹤0.01% | 418 |
|
2024
Q1 | $1.72M | Buy |
20,974
+9,788
| +88% | +$803K | ﹤0.01% | 269 |
|
2023
Q4 | $208K | Sell |
11,186
-28,237
| -72% | -$525K | ﹤0.01% | 1039 |
|
2023
Q3 | $436K | Sell |
39,423
-112,383
| -74% | -$1.24M | ﹤0.01% | 633 |
|
2023
Q2 | $2.37M | Sell |
151,806
-12,457
| -8% | -$195K | ﹤0.01% | 192 |
|
2023
Q1 | $2.85M | Buy |
164,263
+128,120
| +354% | +$2.22M | ﹤0.01% | 144 |
|
2022
Q4 | $340K | Buy |
+36,143
| New | +$340K | ﹤0.01% | 571 |
|
2022
Q3 | – | Hold |
0
| – | – | – | 2297 |
|
2022
Q2 | – | Hold |
0
| – | – | – | 2383 |
|
2022
Q1 | – | Sell |
-16,250
| Closed | -$75K | – | 2630 |
|
2021
Q4 | $75K | Buy |
+16,250
| New | +$75K | ﹤0.01% | 1497 |
|
2021
Q3 | – | Hold |
0
| – | – | – | 2737 |
|
2021
Q2 | – | Hold |
0
| – | – | – | 2655 |
|
2021
Q1 | – | Hold |
0
| – | – | – | 2536 |
|
2020
Q4 | – | Hold |
0
| – | – | – | 2204 |
|
2020
Q3 | – | Hold |
0
| – | – | – | 2054 |
|
2020
Q2 | – | Sell |
-30,615
| Closed | -$145K | – | 2075 |
|
2020
Q1 | $145K | Buy |
+30,615
| New | +$145K | ﹤0.01% | 1040 |
|
2019
Q4 | – | Hold |
0
| – | – | – | 2044 |
|
2019
Q3 | – | Hold |
0
| – | – | – | 1998 |
|
2019
Q1 | – | Sell |
-41,774
| Closed | -$316K | – | 2076 |
|
2018
Q4 | $316K | Sell |
41,774
-26,436
| -39% | -$200K | ﹤0.01% | 829 |
|
2018
Q3 | $1.19M | Buy |
+68,210
| New | +$1.19M | ﹤0.01% | 463 |
|